IQVIA Holdings Inc - ESG Rating & Company Profile powered by AI
If you work at IQVIA Holdings Inc and you wish to use your Sustainability aseessment, please get in touch. Browse to the end of the page for potential risks for IQVIA Holdings Inc based on sector, location and marketcap. This assessment of IQVIA Holdings Inc uses data points from across the internet as well as from available documents by IQVIA Holdings Inc.
IQVIA Holdings Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 5.6; made up of an environmental score of 3.0, social score of 8.0 and governance score of 5.7.
5.6
Medium ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
579 | Tonix Pharmaceuticals Holding Corp | 5.7 | High |
579 | VIVA Biotech Holdings | 5.7 | High |
602 | IQVIA Holdings Inc | 5.6 | High |
602 | Celltrion Inc | 5.6 | High |
602 | Adaptimmune Therapeutics PLC | 5.6 | High |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does IQVIA Holdings Inc have an accelerator or VC vehicle to help deliver innovation?
Does IQVIA Holdings Inc disclose current and historical energy intensity?
Does IQVIA Holdings Inc report the average age of the workforce?
Does IQVIA Holdings Inc reference operational or capital allocation in relation to climate change?
Does IQVIA Holdings Inc disclose its ethnicity pay gap?
Does IQVIA Holdings Inc disclose cybersecurity risks?
Does IQVIA Holdings Inc offer flexible work?
Does IQVIA Holdings Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does IQVIA Holdings Inc disclose the number of employees in R&D functions?
Does IQVIA Holdings Inc conduct supply chain audits?
Does IQVIA Holdings Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does IQVIA Holdings Inc conduct 360 degree staff reviews?
Does IQVIA Holdings Inc disclose the individual responsible for D&I?
Does IQVIA Holdings Inc disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does IQVIA Holdings Inc disclose current and / or historical scope 2 emissions?
Does IQVIA Holdings Inc disclose water use targets?
Does IQVIA Holdings Inc have careers partnerships with academic institutions?
Did IQVIA Holdings Inc have a product recall in the last two years?
Does IQVIA Holdings Inc disclose incidents of discrimination?
Does IQVIA Holdings Inc allow for Work Councils/Collective Agreements to be formed?
Has IQVIA Holdings Inc issued a profit warning in the past 24 months?
Does IQVIA Holdings Inc disclose parental leave metrics?
Does IQVIA Holdings Inc disclose climate scenario or pathway analysis?
Does IQVIA Holdings Inc disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does IQVIA Holdings Inc disclose the pay ratio of women to men?
Does IQVIA Holdings Inc support suppliers with sustainability related research and development?
Does IQVIA Holdings Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does IQVIA Holdings Inc reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is IQVIA Holdings Inc involved in embryonic stem cell research?
Does IQVIA Holdings Inc disclose GHG and Air Emissions intensity?
Does IQVIA Holdings Inc disclose its waste policy?
Does IQVIA Holdings Inc report according to TCFD requirements?
Does IQVIA Holdings Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does IQVIA Holdings Inc disclose energy use targets?
Does IQVIA Holdings Inc disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does IQVIA Holdings Inc have a policy relating to cyber security?
Have a different question?
Potential Risks for IQVIA Holdings Inc
These potential risks are based on the size, segment and geographies of the company.
IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; virtual trials; and strategic planning and design services, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company has a strategic collaboration with HealthCore, Inc. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. IQVIA Holdings Inc. was founded in 1982 and is headquartered in Durham, North Carolina.